Navigation Links
Oxford BioMedica Announces US IND Approval for Novel Ocular Product in Usher Syndrome Type 1B
Date:10/17/2011

OXFORD, England, October 18, 2011 /PRNewswire/ --

-- Third ocular product partnered with Sanofi approved to enter clinical development --

Oxford BioMedica plc ("Oxford BioMedica" or "the Company") (LSE: OXB), the leading gene-based biopharmaceutical company, today announces that the US Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application for the Phase I/IIa clinical development of UshStat®, a novel gene-based treatment for Usher syndrome type 1B.  UshStat® was designed and developed by Oxford BioMedica using the Company's proprietary LentiVector® platform technology and is the third programme to enter clinical development under the Phase I/II ocular collaboration agreement signed with Sanofi in April 2009.

The approval of the IND follows the decision by the US Recombinant DNA Advisory Committee (RAC) to approve the UshStat® Phase I/IIa protocol in May 2011.  The open label, dose escalation Phase I/IIa study will enrol up to 18 patients with Usher syndrome type 1B at the Oregon Health and Science University's Casey Eye Institute, Portland, Oregon.  The study, led by Professor Richard Weleber, will evaluate three dose levels for safety, tolerability and aspects of biological activity and is expected to be initiated by the end of 2011.

Usher syndrome is the most common form of deaf-blindness which affects approximately 30,000-50,000 patients in the US and Europe.  One of the most common subtypes is Usher syndrome type 1B.  The disease is caused by a mutation of the gene encoding myosin VIIA (MY07A), which leads to progressive retinitis pigmentosa combined with a congenital hearing defect.  UshStat® uses the Company's LentiVector® platform technology to deliver a corrected version of the MYO7A gene to address the vision loss associated with the disease.  O
'/>"/>

SOURCE Oxford BioMedica plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. CMC Biologics Licenses Its CHEF1® Expression System to Oxford BioTherapeutics
2. Oxford BioMedica Announces 5T4 Antibody Research Collaboration with ImaginAb
3. Oxford Finance Corporation Sponsors 2010 Mid-Atlantic Bio
4. Oxford Resource Partners, LP and Mendel Biotechnology, Inc. Announce a Miscanthus Biomass Pilot Project in Ohio
5. Oxford Finance Corporation Hires Dr. Killu Sanborn to Support Life Science Business Development in Western North America
6. ALS Therapy Development Institute and Oxford BioMedica Begin Second Phase of Collaboration to Develop Gene Therapies for Amyotrophic Lateral Sclerosis
7. Oxford BioTherapeutics Appoints Michael Moore as Chairman
8. Oxford Performance Materials Introduces OXPEKK PermettaTM High Performance Polymer Films
9. TED Conferences Announces 25 TED Fellows for TEDGlobal in Oxford
10. The Court Supports Bavarian Nordics Decision to Start Patent Infringement Case Against Oxford BioMedica
11. Bavarian Nordics Case Against Oxford BioMedica
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2014)... (PRWEB) August 19, 2014 2014 ... Industry” is a professional and in-depth research report ... basic Linalool information, including its definition, classification, ... industry overview. This research covers the international market ... global industry analysis covering macroeconomic environment & economic ...
(Date:8/18/2014)... --  Sterne, Kessler, Goldstein & Fox P.L.L.C. , an ... , announced today that it has filed eleven ... the U.S. Patent and Trademark Office (USPTO) on behalf ... (Nasdaq: BRLI).  These IPR petitions aim to nullify eleven ... These patents have been asserted against GeneDx in patent ...
(Date:8/18/2014)... August 18, 2014 According ... Market, By Application (Municipal Wastewater Treatment and Industrial ... and Multi Tubular), By Configuration (Internal/Submerged and External/Sidestream), ... by MarketsandMarkets, The market for membrane bioreactor systems ... growing at a CAGR of 15.28% between 2014 ...
(Date:8/18/2014)... , 18. August 2014 Vier ... eine internationale klinische Studie auf, in der ... Linse soll das Sehvermögen bei allen Entfernungen ... Operation möglicherweise keine Lese- oder Gleitsichtbrille mehr ... Namen FluidVision Accommodating Intraocular Lens ...
Breaking Biology Technology:Linalool Industry & Diphenylamine Market (Global, China) 2014 Analysis Now Available at DeepResearchReports.com 2Linalool Industry & Diphenylamine Market (Global, China) 2014 Analysis Now Available at DeepResearchReports.com 3Linalool Industry & Diphenylamine Market (Global, China) 2014 Analysis Now Available at DeepResearchReports.com 4Sterne Kessler Files 11 IPR Petitions On Behalf Of GeneDx, Inc., Subsidiary Of BioReference Laboratories, Inc. 2Sterne Kessler Files 11 IPR Petitions On Behalf Of GeneDx, Inc., Subsidiary Of BioReference Laboratories, Inc. 3Membrane Bioreactor Systems Market Worth $2,927 Million by 2019 2Membrane Bioreactor Systems Market Worth $2,927 Million by 2019 3Implantation einer revolutionären akkommodativen Linse bei Katarakt-Patienten in deutschen Augenzentren im Rahmen einer internationalen klinischen Studie 2Implantation einer revolutionären akkommodativen Linse bei Katarakt-Patienten in deutschen Augenzentren im Rahmen einer internationalen klinischen Studie 3Implantation einer revolutionären akkommodativen Linse bei Katarakt-Patienten in deutschen Augenzentren im Rahmen einer internationalen klinischen Studie 4
... GeoVax Labs, Inc. (OTC,Bulletin Board: GOVX), an ... estimated $15,000,000 Integrated Preclinical/Clinical AIDS,Vaccine Development [IPCAVD] ... This large Grant was awarded by ... & Infectious Disease [NIH-NIAID], an,agency of the ...
... ANN ARBOR, Mich., Sept. 26 MichBio, the,association for ... to be held October 16 in East Lansing. Michigan ... the free event on,its campus. Career Day is intended ... state to educational and career opportunities in,the life sciences. ...
... The landscape of scientific,publications strategy, planning and ... Half of global publications groups are fully,located in ... shift,to medical groups to increase clinical presentation, according ... In a benchmarking study that included such ...
Cached Biology Technology:U.S. Government Awards $15 Million Grant to GeoVax Labs' HIV/AIDS Vaccine Program 2U.S. Government Awards $15 Million Grant to GeoVax Labs' HIV/AIDS Vaccine Program 3MichBio Announces Student Career Day at Michigan State University 2Industry Executives Finding Value in Shift of Scientific Publications 2
(Date:8/19/2014)... bigger brains than counterparts that don,t care for offspring, ... Stickleback fish are well known in the animal kingdom ... rather than the female, cares for offspring. Male sticklebacks ... to find out if the difference in size might ... the study, published recently in Ecology and Evolution ...
(Date:8/18/2014)... The specific composition of bacterial species in a person,s ... Campylobacter , the most common cause of human bacterial ... mBio , the online open-access journal of the American ... Campylobacter infection can yield lasting changes to one,s ... a long time that the microbiota, or microorganisms in ...
(Date:8/18/2014)... Ohio Fish species native to a major Arizona ... habitat by 2050 as surface water flow is reduced ... , Most of these fish species, found in the ... survival relies on easy access to various resources throughout ... the speckled dace (Rhinichthys osculus), roundtail chub (Gila robusta) ...
Breaking Biology News(10 mins):What's in your gut? Certain bacteria may influence susceptibility to infection 2Climate change will threaten fish by drying out Southwest US streams, study predicts 2Climate change will threaten fish by drying out Southwest US streams, study predicts 3
... Spanish and French researchers has undertaken a pioneer analysis ... Areas (MPA) in the Mediterranean and the impact that ... a guarantee for conserving this species., Mediterranean red coral ... jewellery since ancient times. But intensive fishing, particularly in ...
... The U.S. Environmental Protection Agency (EPA) has awarded ... their work in eight key environmental areas: monitoring ... drinking water monitoring, hazardous waste monitoring, water infrastructure, ... year, the companies received "proof of concept" awards ...
... Tufts University,s School of Arts and Sciences has received ... will house a Collaborative Cluster in Genome Structure and ... bring together experts in such areas as genome structure ... to focus on "genome to organism" research to advance ...
Cached Biology News:Marine protected areas conserve Mediterranean red coral 2EPA awards small businesses to develop new environmental technologies 2Tufts wins NCRR grant for Collaborative Cluster in Genome Structure and Developmental Patterning 2Tufts wins NCRR grant for Collaborative Cluster in Genome Structure and Developmental Patterning 3
... Ac-DEVD-CHO is an inhibitor ... The concentration of inhibitor ... activity must be determined ... Ten micromolar inhibitor is ...
Human RELT/TNFRSF19L MAb (Clone 238104)...
homeo box D3, mRNA...
Human TSLP MAb (Clone 258136)...
Biology Products: